CVRx (CVRX) vs Rapid Micro Biosystems (RPID)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Rapid Micro Biosystems (RPID) has outperformed CVRx (CVRX) over the past year, losing 75.7% versus a loss of 81.6%. Over five years, CVRX leads with a -89.3% price change compared with -94.7% for RPID. CVRx is the larger company by market cap ($44.8 million vs $43.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CVRX | RPID |
|---|---|---|
| Share price | $1.68 | $0.8617 |
| Market cap | $44.76M | $43.22M |
| 1-day change | +0.60% | -4.01% |
| YTD return | -76.34% | -69.04% |
| 1-year return | -81.56% | -75.67% |
| 5-year return | -89.27% | -94.66% |
| EPS (TTM) | $-1.97 | $-1.11 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.30 | $4.94 |
| 52-week low | $1.50 | $0.826 |
| Distance from 52-week high | -85.13% | -82.56% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +172.62% | +567.29% |
| Average volume | 917.19K | 271.81K |
| Shares outstanding | 26.64M | 45.66M |
| Employees | 223 | 171 |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About CVRx
CVRX stock →CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex activation therapy, which links the cardiovascular system to the autonomic nervous system.
Healthcare · Medical Devices · 223 employees
About Rapid Micro Biosystems
RPID stock →Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, biologics, medical devices, and personal care products in the United States, Switzerland, Germany, Japan, and internationally. The company offers Growth Direct platform, which includes growth direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Healthcare · Medical Devices · 171 employees
CVRX vs RPID FAQ
Which is bigger, CVRx or Rapid Micro Biosystems?
CVRx (CVRX) is larger, with a market capitalization of $44.76M compared with $43.22M for Rapid Micro Biosystems (RPID).
Which stock has performed better over the past year, CVRX or RPID?
RPID returned -75.67% over the past 12 months, compared with -81.56% for CVRX (price return, excluding dividends). Past performance does not predict future results.
Are CVRx and Rapid Micro Biosystems in the same industry?
Yes. Both are classified in the Medical Devices industry within the Healthcare sector.